Immuno-Oncology
non-CME
HUB
Ajay Maker, MD
Professor
University of California, San Francisco
San Francisco, California, United States
Disclosure information not submitted.
Though impressive responses have been realized with current immune checkpoint blockade immunotherapies, many solid tumors, and specifically GI/HPB cancers, have remained resistant. New and ongoing trials utilizing bispecific antibodies and adoptive cell therapies are revealing promise for the treatment of these cancers. The purpose of this session is to update the audience on novel antibodies and T-cell therapies for these diseases and the role of the surgical oncologist in developing and utilizing these technologies.
HUB Presenter: Jonathan M. Hernandez, MD – Surgical Oncology Program, National Cancer Institute
HUB Presenter: Stephanie L. Goff, MD – Surgery Branch, National Cancer Institute